Pauline Beauquel (M2)

Characterization of a sporadic mouse model TDP-43

Charlotte Branquart (D2)

Platelet biomaterials and tauopathy

Léna Chesnais (D2)

Role of Tau pathology and astrocytic A2A adenosine receptors in depressive symptoms associated with Alzheimer's disease.

Camille Degryse (D3)

Neutrophils and NET in Tauopathies

Violette Delforge (D3)

Pathophysiology of RFC1 expansions in parkinsonian syndromes

Giovanni Ferro (D3)

Immunotherapeutic approaches using anti-Tau nanobodies in Tauopathies

Eloïse Gilbert (M2)

Role of oral and intestinal microbiota in the genesis and progression of tauopathies

Marine Hervet (D3)

Role of A2A adenosine receptors in the pathophysiological development of a tauopathy model

Evangelia Manousaki (D3)

Pathological forms of Tau and their impact

Thibaud Nicot (D2)

Neuron-astrocyte interactions in the context of Alzheimer's disease: modeling using a microfluidic system and MEA

Anne Pernodet (D2)

Capturing age-related degenerative pathology in tauopathies

Abinaya Srinivasan (D1)

Platelet biomaterials, neurogenesis and olfaction

Simon Thiou (D3)

Development of a Tau-specific intracellular degradation system: towards a new therapeutic approach for the treatment of tauopathies